Moreover, NPY raises the risk of obesity by upregulating NPY and NPY2R expression in the abdominal fat and its administration in rodents leads to lipogenic enzyme activation in adipose tissues (36), demonstrating its critical role in adipogenesis. This evidence concerns the gene NPY and obesity due to melanocortin 4 receptor deficiency.